Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review

Cephalalgia

Volumn 34, Issue 6, 2014, Pages 409-425

  Westergaard, Maria L ^a   Hansen, Ebba Holme ^b   Glümer, Charlotte ^c,d   Olesen, Jes ^a   Jensen, Rigmor H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Research Center for Prevention and Health   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Chronic headache; classification; epidemiology; International Classification of Headache Disorders; medication overuse headache; prevalence

Indexed keywords

CHRONIC DAILY HEADACHE; COMPARATIVE STUDY; CULTURAL ANTHROPOLOGY; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; HEADACHE; HUMAN; NOMENCLATURE; POPULATION RESEARCH; PREVALENCE; REVIEW; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; CLASSIFICATION; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HEADACHE DISORDERS, SECONDARY; STANDARDS;

CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; HEADACHE DISORDERS, SECONDARY; HUMANS; PREVALENCE;

EID: 84899021817     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413512033     Document Type: Review

References (116)

1. Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004; 3: 475-483
2. Katsarava Z, Jensen R. Medication-overuse headache: Where are we now?. Curr Opin Neurol. 2007; 20: 326-330
3. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication overuse headache. Lancet Neurol. 2010; 9: 391-401
4. Diener HC, Katsarava Z, Limmroth V. Headache attributed to a substance or its withdrawal. Handb Clin Neurol. 2010; 97: 589-599
5. Classification of Headache. JAMA. 1962; 179: 717-718
6. Wilkinson M Drug-induced headache. Diener HC Wilkingson M, ed. Berlin: Springer-Verlag; 1988: 1-2.
7. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8: 1-96
8. Silberstein SD, Lipton RB, Solomon S, et al. Classification of daily and near-daily headaches: Proposed revisions to the IHS criteria. Headache. 1994; 34: 1-7
9. The International Classification of Headache Disorders. Cephalalgia. 2004; 24: 1-160
10. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005; 25: 460-465
11. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746
12. Olesen J, Steiner T, Bousser M-G, et al. Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia. 2009; 29: 1331-1336
13. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629-808
14. Rasmussen BK, Jensen R, Olesen J Headache classification and epidemiology. Olesen J, ed. New York: Raven Press; 1994: 69-76.
15. Sun-Edelstein C, Bigal ME, Rapoport AM. Chronic migraine and medication overuse headache: Clarifying the current International Headache Society classification criteria. Cephalalgia. 2008; 29: 445-452
16. Ferrari A, Coccia C, Sternieri E. Past, present, and future prospects of medication overuse headache classification. Headache. 2008; 48: 1096-1102
17. Olesen J. Analgesic headache. BMJ. 1995; 310: 479-480
18. Srikiatkhachorn A, Maneesri S, Govitrapong P, et al. Derangement of serotonin system in migrainous patients with analgesic abuse headache: Clues from platelets. Headache. 1998; 38: 43-49
19. Isler H. Treatment of analgesic-induced headache [in German]. Ther Umsch. 1986; 43: 221-225
20. Edmeads J. Analgesic-induced headaches: An unrecognized epidemic. Headache. 1990; 30: 614-615
21. Adelman JU. Analgesic induced headache. N C Med J. 1991; 52: 345-346
22. Kudrow L Drug-induced headache. Diener HC Wilkinson M, ed. Berlin: Springer-Verlag; 1988:
23. Diener HC, Dichgans J, Scholz E, et al. Analgesic-induced chronic headache: Long-term results of withdrawal therapy. J Neurol. 1989; 236: 9-14
24. Rapoport AM. Analgesic rebound headache. Headache. 1988; 28: 662-665
25. Dichgans J, Diener HC, Gerber WD, et al. Chronic analgesic-induced headache [in German]. Dtsch Med Wochenschr. 1984; 109: 369-373
26. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-550
27. Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001; 21: 878-883
28. Young WB, Silberstein SD. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001; 21: 873-873
29. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia. 2003; 23: 963-971
30. Linton-Dahlöf P, Linde M, Dahlöf C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: A retrospective study. Cephalalgia. 2000; 20: 658-662
31. Antonaci F. Drug abuse headache: Recognition and management. Cephalalgia. 1998; 18: 47-52
32. Diener HC. A personal view of the classification and definition of drug dependence headache. Cephalalgia. 1993; 13 (Suppl 12): 68-71
33. Bekkelund SI, Salvesen R. Drug-associated headache is unrecognized in patients treated at a neurological centre. Acta Neurol Scand. 2002; 105: 120-123
34. Silverman AP. Behavioural changes in rats suggesting drug-induced headache [proceedings]. Br J Pharmacol. 1976; 58: 439P-440P
35. Allain HJ, Weintraub M. Drug induced headache. Ration Drug Ther. 1980; 14: 1-6
36. Diener HC, Wilkinson M Drug-induced headache. Berlin: Springer-Verlag; 1988:
37. Silberstein SD. Drug-induced headache. Neurol Clin. 1998; 16: 107-123
38. Spierings EL. Prednisone as initial treatment of drug-induced daily headache. Cephalalgia. 2000; 20: 748-748
39. Tribl GG, Schnider P, Wöber C, et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache?. Cephalalgia. 2001; 21: 691-696
40. Mathew NT, Kurman R, Perez F. Drug induced refractory headache-clinical features and management. Headache. 1990; 30: 634-638
41. Moore KL, Noble SL. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache. Am Fam Physician. 1997; 56: 2039-2048, 2051-2054
42. Askmark H, Lundberg PO, Olsson S. Drug-related headache. Headache. 1989; 29: 441-444
43. Diener HC, Tfelt-Hansen P The headaches. Olesen J Tfelt-Hansen P Welch KMA, ed. New York: Raven Press Ltd; 1993: 721-727.
44. Diener HC, Dahlof CG The headaches. Olesen J Tfelt-Hansen P Welch KMA, ed. Philadelphia: Lippincott Williams & Wilkins; 1999: 871-878.
45. Panconesi A, Del Bianco PL, Curradi C, et al. Headache caused by analgesic and/or ergotamine abuse [in Italian]. Clin Ter. 1991; 137: 169-183
46. Parajuá Pozo JL, Ballesteros Martínez E. Headache caused by analgesic abuse [in Spanish]. Aten Primaria. 1994; 14: 547-549
47. Lantéri-Minet M. Headaches caused by analgesic abuse [in French]. Pathol Biol (Paris). 2000; 48: 707-714
48. Parajua Pozo JL, Serra Mestres J, López Pousa S. Headache caused by ergotamine addiction [in Spanish]. Rev Clin Esp. 1991; 189: 347-347
49. Peters GA, Horton BT. Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med. 1950; 36: 972-973
50. Feoktistov AP, Filatova EG, VeiËñ AM. Medication abuse-related headache [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 1999; 99: 58-61
51. Hering R, Glover V, Pattichis K, et al. 5HT in migraine patients with medication-induced headache. Cephalalgia. 1993; 13: 410-412
52. Zed PJ, Loewen PS, Robinson G. Medication-induced headache: Overview and systematic review of therapeutic approaches. Ann Pharmacother. 1999; 33: 61-72
53. Mathew NT. Medication misuse headache. Cephalalgia. 1998; 18: 34-36
54. Klapper JA. Denial of hospitalization by insurers for inpatient treatment of medication rebound headaches. Headache. 1994; 34: 601-602
55. Evans RW. Warning: The Excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache. Headache. 1999; 39: 679-680
56. Silberstein SD, Welch KM. Painkiller headache. Neurology. 2002; 59: 972-974
57. Page H. 'Rebound headache' from ergotamine withdrawal. JAMA. 1981; 246: 719-719
58. Couch JR. Rebound-withdrawal headache (medication overuse headache). Curr Treat Options Neurol. 2006; 8: 11-19
59. Andersson PG. Ergotamine headache. Headache. 1975; 15: 118-121
60. Rowsell AR, Neylan C, Wilkinson M. Ergotamine induced headaches in migrainous patients. Headache. 1973; 13: 65-67
61. Shea PE. Drug-and caffeine-induced headaches. CMAJ. 1997; 157: 510-510
62. Göbel H, Stolze H, Heinze A, et al. Easy therapeutical management of sumatriptan-induced daily headache. Neurology. 1996; 47: 297-298
63. Shorofsky MA, Lamm RN. Caffeine-withdrawal headache and fasting. N Y State J Med. 1977; 77: 217-218
64. Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001; 57: 1694-1698
65. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009; 6: e1000100-e1000100
66. Booth A. How much searching is enough? Comprehensive versus optimal retrieval for technology assessments. Intl J of Technology Assess Health Care. 2010; 26: 431-435
67. Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27: 193-210
68. Scher A, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008; 48: 16-25
69. Stovner LJ, Andree C. Prevalence of headache in Europe: A review for the Eurolight project. J Headache Pain. 2010; 11: 289-299
70. Stark RJ, Ravishankar K, Siow HC, et al. Chronic migraine and chronic daily headache in the Asia-Pacific region: A systematic review. Cephalalgia. 2013; 33: 266-283
71. Castillo J, Muñoz P, Guitera V, et al. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999; 39: 190-196
72. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up. Neurology. 2000; 54: 314-319
73. Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: Prevalence, follow-up and outcome predictors. Cephalalgia. 2001; 21: 980-986
74. Prencipe M, Casini AR, Ferretti C, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001; 70: 377-381
75. Scher AI, Stewart WF, Lipton RB. Is analgesic use a risk factor for chronic daily headache?. Neurology. 2001; 56: A312-A312
76. Scher AI, Lipton LR, Stewart WF, et al. Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study. Cephalalgia. 2010; 30: 321-328
77. Colás R, Muñoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology. 2004; 62: 1338-1342
78. Zwart JA, Dyb G, Hagen K, et al. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology. 2004; 62: 1540-1544
79. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, et al. Chronic frequent headache in the general population: Prevalence and associated factors. Cephalalgia. 2006; 26: 1434-1442
80. Dyb G, Holmen TL, Zwart JA. Analgesic overuse among adolescents with headache: The Head-HUNT-Youth Study. Neurology. 2006; 66: 198-201
81. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in adolescents. Prevalence, impact, and medication overuse. Neurology. 2006; 66: 193-197
82. Aaseth K, Grande RB, Kværner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008; 28: 705-713
83. Aaseth K, Grande RB, Lundkvist C, et al. What is chronic headache in the general population? The Akershus study of chronic headache. Acta Neurol Scand. 2009; 120: 30-32
84. Rueda-Sánchez M, Díaz-Martínez LA. Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia. 2008; 28: 216-225
85. Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study. Cephalalgia. 2010; 30: 207-213
86. Katsarava Z, Dzagnidze A, Kukava M, et al. Primary headache disorders in the Republic of Georgia: Prevalence and risk factors. Neurology. 2009; 73: 1796-1803
87. Da Silva A, Costa EC, Gomes JB, et al. Chronic headache and comorbibities: A two-phase, population-based, cross-sectional study. Headache. 2010; 50: 1306-1312
88. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011; 31: 1015-1022
89. Jonsson P, Linde M, Hensing G, et al. Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication overuse headache. J Headache Pain. 2012; 13: 281-290
90. Lipton RB, Manack A, Ricci JA, et al. Prevalence and burden of chronic migraine in adolescents: Results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011; 51: 693-706
91. Linde M, Stovner LJ, Zwart JA, et al. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia. 2011; 31: 585-596
92. Chu MK, Oh K, Kim B-K, et al. Prevalence and impact of chronic daily headache in Korea: Results from Korean headache survey. Cephalalgia. 2011; 31 (Suppl 1): 138-139
93. Shahbeigi S, Fereshtehnejad SM, Mohammadi N, et al. Epidemiology of headaches in Tehran urban area: A population-based cross-sectional study in district 8, year 2010. Neurol Sci. 2013; 34: 1157-1166
94. Ertas M, Baykan B, Orhan EK, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: A nationwide home-based study in adults. J Headache Pain. 2012; 13: 147-157
95. Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in China: A population-based door-to-door survey. Headache. 2012; 52: 582-591
96. Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: A countrywide survey. Cephalalgia. 2012; 32: 373-381
97. Hagen K, Linde M, Steiner TJ, et al. Risk factors for medicine over-use headache: An 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain. 2012; 153: 56-61
98. Hagen K, Zwart JA, Vatten L, et al. Head-HUNT: Validity and reliability of a headache questionnaire in a large population-based study in Norway. Cephalalgia. 2000; 20: 244-251
99. Katsarava Z, Kukava M, Mirvelashvili E, et al. A pilot methodological validation study for a population-based survey of the prevalences of migraine, tension-type headache and chronic daily headache in the country of Georgia. J Headache Pain. 2007; 8: 77-82
100. Hagen K, Zwart JA, Aamodt AH, et al. The validity of questionnaire-based diagnoses: The third Nord-Trøndelag Health Study 2006-2008. J Headache Pain. 2010; 11: 67-73
101. Ayzenberg I, Katsarava Z, Mathalikov R, et al. The burden of headache in Russia: Validation of the diagnostic questionnaire in a population-based sample. Eur J Neurol. 2011; 18: 454-459
102. Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002; 59: 1011-1014
103. Maizels M, Burchette R. Rapid and sensitive paradigm for screening patients with headache in primary care settings. Headache. 2003; 43: 441-450
104. Haag G. Medication overuse headache-comments on the current International Headache Society classification criteria. Cephalalgia. 2010; 30: 1409-1411
105. Abrignani G, Ferrante T, Castellini P, et al. Description and validation of an Italian ICHD-II-based questionnaire for use in epidemiological research. Headache. 2012; 52: 1262-1282
106. Rao GN, Kulkarni GB, Gururaj G, et al. The burden of headache disorders in India: Methodology and questionnaire validation for a community-based survey in Karnataka State. J Headache Pain. 2012; 13: 543-550
107. Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012; 25: 290-295
108. Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006; 46: 766-772
109. Bigal ME, Tepper SJ, Sheftell FD, et al. Chronic daily headache: Correlation between the 2004 and 1998 International Headache Society Diagnostic Criteria. Headache. 2004; 44: 684-691
110. Bigal ME, Rapoport AM, Tepper SJ, et al. The classification of chronic daily headache in adolescents-A comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache. 2005; 45: 582-589
111. Zeeberg P, Olesen J, Jensen R. Medication overuse headache and chronic migraine in a specialized headache centre: Field-testing proposed new appendix criteria. Cephalalgia. 2009; 29: 214-220
112. Wang SJ, Fuh JL. Medication overuse headache in Taiwan. Cephalalgia. 2008; 28: 1240-1242
113. Midgette LA, Scher AI. The epidemiology of chronic daily headache. Curr Pain Headache Rep. 2009; 13: 59-63
114. Yu SY, Cao XT, Zhao G, et al. The burden of headache in China: Validation of diagnostic questionnaire for a population-based survey. J Headache Pain. 2011; 12: 141-146
115. Vincent MB. Controversy over the classification of medication overuse headache. Curr Pain Headache Rep. 2012; 16: 80-85
116. Sampson M, McGowan J, Cogo E, et al. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009; 62: 944-952